The hybrid injectables HA-CaHA and HA-CaHA-L are effective and safe for up to 1 year for the treatment of midface volume deficit.
Lithoz's booth at Formnext 2025 will be dedicated to real-life applications additively manufactured via its proprietary LCM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback